Loading...
FGFR1 underlies obesity-associated progression of estrogen receptor–positive breast cancer after estrogen deprivation
Obesity increases breast cancer mortality by promoting resistance to therapy. Here, we identified regulatory pathways in estrogen receptor–positive (ER-positive) tumors that were shared between patients with obesity and those with resistance to neoadjuvant aromatase inhibition. Among these was fibro...
Na minha lista:
| Udgivet i: | JCI Insight |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Clinical Investigation
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6124402/ https://ncbi.nlm.nih.gov/pubmed/30046001 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.120594 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|